Icahn School of Medicine at Mount Sinai
New York · Founded 1963
About Icahn School of Medicine at Mount Sinai
The Mount Sinai School of Medicine in New York, New York, one of the only schools in the nation with a distinctive Department of Medical Education that continually improves the quality of its teaching, offers students a variety of medical academics to shape them into compassionate assistants, professionals and industry leaders. The academics available at Mount Sinai include master's and PhD programs in areas like: * Science and Medicine * Patient Oriented Research Training and Leadership * Biomedical Sciences * Genetic Counseling * Clinical Research Besides its degree-granting programs, Mount Sinai also offers an extensive number of residencies and fellowships, some of which include: * Anesthesiology * Cardiology * Dental Medicine * Emergency Medicine * Hematology and Oncology College life at Mount Sinai is fully-immersed in the medical sciences. All your instruction, provided by medical professionals, will be delivered in a hospital setting, allowing you to familiarize yourself with the many resources and technology used in today's hospitals. Mount Sinai is also home to the Levy Library, which is fully-stocked with myriad medical resources, from journals to professional magazines to textbooks. Since each program has different admissions requirements, please contact Mount Sinai for more information on a program that interests you and your career goals. Tuition assistance is available to students through fellowship programs and Mount Sinai grants and scholarships. For more information federal sources of financial aid, please contact an aid advisor from the school.
Company Facts
- Founded: 1963
- Operating status: Operating
- IPO status: Private
- Employees: 5,001 – 10,000
- Estimated revenue: $500K – $1M
- Total funding: $11.3M
- Last round: Grant (Jul 2024)
- Website: icahn.mssm.edu
- Phone: +1 212-241-8884
Social Profiles
Canonical: https://fsome.com/organization/icahn-school-of-medicine-at-mount-sinai-8417561 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.